Dermatologist Dr. Tamara Kopp from Juvenis in Vienna

Reviews

Here you have the opportunity to read personal reviews and give your own rating:

Google Docfinder Doctify logo

Curriculum Vitae - Curriculum vitae of
a.o. Univ. Prof. Dr. med. Tamara Kopp

Focal points

  • Skin cancer screening/moles check: white and black skin cancer
  • Dermatological surgery: removal of moles, warts, white and black skin cancer
  • Aesthetic dermatology: Injectable treatments with botulinum toxin (Botox), hyaluronic acid, etc.
  • Laser medicine: skin rejuvenation, pigment spots, melasma, veins, couperose
  • Radiofrequency microneedling
  • Allergy diagnostics and treatment: allergen chip, prick test, epicutaneous test, laboratory diagnostics, specific immunotherapy
  • Pigment disorders: Melasma, lentigines solares
  • Acne: acne vulgaris, acne rosacea, couperose
  • Peelings (TCA & fruit acid)
  • Psoriasis

Education & professional activities

Professional activity Period
Owner of JUVENIS June 1, 2021
Founding partner of JUVENIS october 2012
Surgery at the Vienna Private Clinic 2004 to 2012
Senior physician at the University Clinic for Dermatology, Vienna General Hospital 2004 to 2012
Ward manager and head of the allergy outpatient clinic
International Management Project
Medical University of Vienna International (MUVI) and
Voest Alpine Medicine (VAMED)
Prince Court Medical Center SDN BHD (PCMC)Kuala Lumpur, Malaysia
July 4, 2007
Venia docendi and appointment as associate university professor 2004
Specialist training in dermatology and venereology, Vienna General Hospital 1997 to 2004
Dissertation and post-doctoral fellowship at the Harvard Skin Disease Research Center, Harvard University, Boston, MA, USA and
Research work at the University Clinic for Dermatology, Vienna General Hospital
1993 to 1997
Doctorate in medicine at the University of Vienna 1994

Awards and prizes

Awards Period
Heinrich Auspitz Prize of the ÖGDV award winners 2015
Award 2004 - "Theodor Billroth Prize" 2004
UNILEVER Prize winners 2003

Publications

Publications Period
Clinical improvement in psoriasis with specific targeting of interleukin-23.ÖGDV Award Winner
Kopp T, Riedl E, Bangert C, Bowman EP, Greisenegger E, Horowitz A, Kittler H, Blumenschein
WM, McClanahan TK, Marbury T, Zachariae C, Xu D, Hou XS, Mehta A, Zandvliet AS,
Montgomery D, van Aarle F, Khalilieh S.
Nature. 2015 May 14;521(7551):222-6.
May 14, 2015
Specific roles for dendritic cell subsets during initiation and progression of psoriasis
Glitzner E, Korosec A, Brunner PM, Drobits B, Amberg N, Schonthaler HB, Kopp T, Wagner EF,
Stingl G, Holcmann M, Sibilia M.
EMBO Mol Med. 2014 Sep 12;6 (10):1312-27
Sept. 12, 2014
Association of the chromosome 11q13.5 variant with atopic dermatitis in Austrian patients
Greisenegger EK, Zimprich F, Zimprich A, Gleiss A, Kopp T.
Eur J Dermatol. 2013 Apr 1;23(2):142-5.
April 2013
Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis
Greisenegger EK, Novak N, Maintz L, Bieber T, Zimprich F, Haubenberger D, Gleiss A, Stingl G, Kopp T*, Zimprich A*.
*Equally contributing authors
(J Eur Acad Dermatol Venereol. 2010; 24:607-610)/
2010
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.
G. Stary, C. Bangert, M. Tauber, R. Strohal, *T. Kopp, *G. Stingl.
Equal last authorship
(J. Exp. Med 2007; 204:1441-51)
2007
Immunopathologic features of allergic contact dermatitis in man: participation of plasmacytoid dendritic cells in the pathogenesis of the disease?
C. Bangert, J. Friedl, G. Stary, G. Stingl, T. Kopp
(J. Invest. Dermatol., 2003; 121:1409-1418)
2003
IL-23 production by cosecretion of transgenic p40 with endogenous p19 in K14/p40 transgenic mice. Evidence for enhanced cutaneous immunity.
T. Kopp, P. Lenz, C. Bello-Fernandez, R. Kastelein, T.S. Kupper and G. Stingl
(J. Immunol., 2003; 170:5438-5444)
2003
Inflammatory skin disease in K14/p40 transgenic mice. Evidence for IL-12-like activities of p40
T. Kopp, J.D. Kieffer, A. Rot, S. Strommer, G. Stingl and T.S. Kupper
(J. Invest. Dermatol., 2001; 117: 618-626)
2001
Keratinocyte expression of the type 2 IL-1 receptor (IL-1R2) mediates local and specific inhibition of IL-1 mediated inflammation
T. Rauschmayr, R. W. Groves and T.S. Kupper
(Proc.Natl.Acad.Sci.U.S.A. 1997; 94:5814-5819)
1997
Distinct roles for B7 costimulation in contact hypersensitivity and humoral immune responses to epicutaneous antigen
T. Rauschmayr-Kopp, I.R. Williams, F. Borriello, A.H. Sharpe and T.S. Kupper
(Eur. J. Immunol., 1998; 28:4221-4227)
1998

Memberships

ISAC certified 2022 member ISAC certified 2023 member ISAC certified 2024 member

Languages

  • German and English

...what does attractiveness mean to you?

For me, attractiveness means a successful cocktail of personality, charisma, charisma, appearance and outer beauty.